SPARCL1 and cardiovascular disorder: CELSR2, FN1, SPARCL1, APOE, LPA, APOA5, and TGFB1 exhibit causal associations with both atherosclerosis and four cardiovascular diseases, suggesting their potential as therapeutic targets for atherosclerosis.